Results 151 to 160 of about 2,731,118 (178)

Uncovering the environmental dissemination of mobile tigecycline resistance

open access: yeshLife
William Calero-Cáceres   +8 more
openaire   +1 more source

[Bacterial resistance and a new antibiotic: tigecycline].

open access: yesRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006
openaire   +1 more source

The Emergence of Clinical Resistance to Tigecycline

International Journal of Antimicrobial Agents, 2013
Tigecycline (TIG) exhibits broad-spectrum activity against many Gram-positive and Gram-negative pathogens. However, clinical resistance has emerged recently and has been detected following treatment with TIG. This observation suggests that long-term monotherapy may carry a high risk for TIG resistance.
Yun Cai, Rui Wang, Xu Liu
exaly   +3 more sources

Overexpression of AdeABC Efflux Pump Associated With Tigecycline Resistance in Clinical Acinetobacter nosocomialis Isolates

open access: yesClinical Microbiology and Infection, 2019
[[abstract]]Objectives: Tigecycline non-susceptible Acinetobacter nosocomialis (TNAN) has been discovered in clinical isolates. The resistance-nodulation-cell division (RND)-type efflux system plays a major role in tigecycline non-susceptible ...
Jun-Ren Sun, T -L Chen, S -C Kuo
exaly   +2 more sources

Current Perspectives on Tigecycline Resistance in Enterobacteriaceae: Susceptibility Testing Issues and Mechanisms of Resistance

open access: yesInternational Journal of Antimicrobial Agents, 2016
During the past decades, rates of multidrug-resistant (MDR) and carbapenem-resistant (CR) Enterobacteriaceae clinical isolates, mainly Klebsiella spp., Escherichia coli, Enterobacter spp., Proteus spp.
Spyros Pournaras   +2 more
exaly   +2 more sources

Roles of ramR and Tet(A) Mutations in Conferring Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.

open access: yesAntimicrobial Agents and Chemotherapy, 2017
[[abstract]]Tigecycline is regarded as a last-resort treatment for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections, but increasing numbers of tigecycline-resistant K. pneumoniae isolates have been reported.
Feng-Yee Chang   +2 more
exaly   +2 more sources

Development mechanism of resistant population post-exposure to tigecycline in tigecycline-heteroresistant Acinetobacter baumannii strain

International Journal of Antimicrobial Agents, 2023
Tigecycline heteroresistance is highly prevalent in Acinetobacter baumannii clinical isolates, reducing the efficacy of tigecycline treatment. This study investigated the population dynamics of A. baumannii with tigecycline heteroresistance to determine the origin of resistance that occurs over time after antibiotic exposure.
Jeongwoo Jo   +3 more
openaire   +2 more sources

RshA mutations contributing to tigecycline resistance in Mycobacteroides abscessus

Journal of Medical Microbiology, 2022
Tigecycline is an important rescue antibiotic for many bacterial infections. In Mycobacteroides abscessus , tigecycline resistance has been associated with dysregulated stress response caused by aberrations in the interaction of the SigH and RshA factors.
Kar Men Aw   +4 more
openaire   +2 more sources

Update on Prevalence and Mechanisms of Resistance to Linezolid, Tigecycline and Daptomycin in Enterococci in Europe: Towards a Common Nomenclature [PDF]

open access: yesDrug Resistance Updates, 2018
International audienceVancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptides often fail.
Jennifer K Bender   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy